Indexiq Advisors Llc decreased its stake in Summit Hotel Pptys Inc (INN) by 51.11% based on its latest 2018Q1 regulatory filing with the SEC. Indexiq Advisors Llc sold 103,468 shares as the company’s stock rose 11.14% while stock markets declined. The institutional investor held 98,960 shares of the consumer services company at the end of 2018Q1, valued at $1.35 million, down from 202,428 at the end of the previous reported quarter. Indexiq Advisors Llc who had been investing in Summit Hotel Pptys Inc for a number of months, seems to be less bullish one the $1.49B market cap company. The stock decreased 0.21% or $0.03 during the last trading session, reaching $14.18. About 632,001 shares traded. Summit Hotel Properties, Inc. (NYSE:INN) has declined 14.43% since June 20, 2017 and is downtrending. It has underperformed by 27.00% the S&P500. Some Historical INN News: 07/03/2018 Agilysys Solutions Selected by The Summit Hotel, Cincinnati to Optimize Efficiency and Enhance the Guest Experience; 02/05/2018 – Summit Hotel 1Q EPS 1c; 20/04/2018 – DJ Summit Hotel Properties Inc, Inst Holders, 1Q 2018 (INN); 05/04/2018 – SUMMIT HOTEL PROPERTIES – ON MARCH 31, BOARD NAMED JONATHAN CF; 02/05/2018 – Summit Hotel 1Q Rev $140.2M; 30/03/2018 – Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurgery, The KEYW Holding, FARO; 02/05/2018 – Summit Hotel 1Q FFO 31c/Shr; 07/03/2018 – Norges Bank Buys New 1.1% Position in Summit Hotel; 05/04/2018 – SUMMIT HOTEL PROPERTIES INC – ON MARCH 31 CFO, GREGORY DOWELL RETIRED FROM CO; 30/04/2018 – Summit Hotel Properties Declares First Quarter 2018 Dividends
Annex Advisory Services Llc decreased its stake in Johnson & Johnson (JNJ) by 71.24% based on its latest 2018Q1 regulatory filing with the SEC. Annex Advisory Services Llc sold 7,436 shares as the company’s stock declined 8.03% with the market. The institutional investor held 3,002 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $385,000, down from 10,438 at the end of the previous reported quarter. Annex Advisory Services Llc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $328.75 billion market cap company. The stock increased 1.03% or $1.25 during the last trading session, reaching $122.57. About 8.57 million shares traded or 28.72% up from the average. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 20, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 16/05/2018 – Johnson & Johnson is courting health-conscious millennial moms by relaunching its baby shampoo; 02/05/2018 – Johnson & Johnson’s Janssen Biotech to Acquire BeneVir Biopharm; 24/05/2018 – Is Hank Fuchs tearing up about JJ?; 23/03/2018 – A Late Johnson & Johnson Heiress’ Manhattan Town House Complete With a Nightclub; 19/03/2018 – AstraZeneca Presents New Data Evaluating Safety and Efficacy of FARXIGA in Patients with Type 2 Diabetes and Moderate Renal Impairment; 14/05/2018 – J&J defends itself in trial over baby powder asbestos claims; 18/04/2018 – Kentucky accuses J&J of contributing to opioid epidemic; 17/04/2018 – J&J SAYS ESTIMATES THAT ABOUT 70% OF CUMULATIVE PRE-TAX COSTS RELATING TO GLOBAL SUPPLY CHAIN ACTIONS WILL RESULT IN CASH OUTLAYS – SEC FILING; 26/03/2018 – Hartford Dividend & Growth HLS Adds AT&T, Cuts J&J; 29/03/2018 – lnvokana (canagliflozin; Johnson & Johnson/Mitsubishi Tanabe/Daiichi Sankyo) Drug Analysis 2018 – ResearchAndMarkets.com
Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.06 EPS, up 12.57% or $0.23 from last year’s $1.83 per share. JNJ’s profit will be $5.53B for 14.88 P/E if the $2.06 EPS becomes a reality. After $2.06 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Annex Advisory Services Llc, which manages about $827.76M and $549.77M US Long portfolio, upped its stake in Fiserv Inc (NASDAQ:FISV) by 7,267 shares to 16,821 shares, valued at $1.20 million in 2018Q1, according to the filing. It also increased its holding in Southwest Airls Co (NYSE:LUV) by 5,595 shares in the quarter, for a total of 35,681 shares, and has risen its stake in Select Sector Spdr Tr (XLY).
Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $20.17 million activity.
Investors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It is positive, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Outfitter Advsr Ltd accumulated 12,072 shares or 0.71% of the stock. Jacobs Levy Equity Management, New Jersey-based fund reported 84,130 shares. Hgk Asset stated it has 117,879 shares. 454,707 are held by Atalanta Sosnoff Capital Limited Liability. 1.25 million were accumulated by Epoch Inv Prtn. Alps Advsrs holds 0.02% in Johnson & Johnson (NYSE:JNJ) or 15,060 shares. Bp Plc holds 306,000 shares. Jpmorgan Chase Com reported 23.35 million shares. Check Mngmt Ca owns 2,973 shares or 0.02% of their US portfolio. Salem Mngmt Inc has 59,015 shares for 4.11% of their portfolio. Condor accumulated 120,203 shares. Cim Limited Liability, New York-based fund reported 2,297 shares. Mirador Capital Prtn Limited Partnership reported 0.7% of its portfolio in Johnson & Johnson (NYSE:JNJ). Geller Limited Liability Corporation stated it has 28,614 shares or 1.79% of all its holdings. Skba Mgmt Limited Liability Corp holds 3,100 shares.
More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” on June 01, 2018, also Fool.com with their article: “Better Buy: Johnson & Johnson vs. Eli Lilly” published on June 17, 2018, Benzinga.com published: “A Look Back At What’s Happened To Each Sector Through The First Half Of 2018 (Part 2)” on June 19, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Recent Purchase: Johnson & Johnson” published on June 14, 2018 as well as Fool.com‘s news article titled: “3 Stocks That Are Absurdly Cheap Right Now” with publication date: June 19, 2018.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, October 14 by S&P Research. As per Wednesday, April 20, the company rating was maintained by Goldman Sachs. JP Morgan upgraded Johnson & Johnson (NYSE:JNJ) on Monday, May 15 to “Overweight” rating. The stock has “Buy” rating by Jefferies on Wednesday, October 18. The stock of Johnson & Johnson (NYSE:JNJ) earned “Underweight” rating by Alembic on Friday, July 21. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, July 20 with “Outperform” rating. Jefferies upgraded the shares of JNJ in report on Wednesday, October 11 to “Buy” rating. Credit Suisse maintained it with “Outperform” rating and $151 target in Friday, April 20 report. Goldman Sachs upgraded it to “Neutral” rating and $112 target in Monday, March 14 report. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Wednesday, April 18 by Wells Fargo.
Analysts await Summit Hotel Properties, Inc. (NYSE:INN) to report earnings on August, 1. They expect $0.38 EPS, up 5.56% or $0.02 from last year’s $0.36 per share. INN’s profit will be $39.90 million for 9.33 P/E if the $0.38 EPS becomes a reality. After $0.31 actual EPS reported by Summit Hotel Properties, Inc. for the previous quarter, Wall Street now forecasts 22.58% EPS growth.
Indexiq Advisors Llc, which manages about $1.21B and $3.11 billion US Long portfolio, upped its stake in Vanguard Bd Index Fd Inc (BND) by 25,872 shares to 54,593 shares, valued at $4.36 million in 2018Q1, according to the filing. It also increased its holding in Almost Family Inc (NASDAQ:AFAM) by 10,735 shares in the quarter, for a total of 37,162 shares, and has risen its stake in Aflac Inc (NYSE:AFL).